StartUp Health Insights Report - Digital Health Funding Data 2015 Q1StartUp Health
What happened in the beginning of 2015?
~Investors backed later stage digital health companies as the market matures
~Funding in breakout metro areas including San Diego and Denver grew significantly, but the Bay Area continues to lead with $390M
~Wellness startups increased in popularity to become the second most active subsector
~Close to 41% of all digital health funding YTD has 50+ relevance
StartUp Health Insights Digital Health Funding Rankings Q3 2015 ReportStartUp Health
Q3 2015 continues to demonstrate a trend towards digital health market maturity with an increase of investment dollars combined with larger, less frequent deals.
~ Benefits and insurance solutions remain at the top of the deals list for 2015, particularly as these businesses become more capital intensive. Genomics companies are also beginning to attract funding as the line between biotech and consumer health blurs.
~ While it’s no surprise that the Bay Area continues to bring in the most funding YTD, newer markets are also growing. With Chicago, Salt Lake City and South Florida each taking in over $125M, it’s clear that investment opportunities are everywhere.
~ Keeping with last year’s trend, seed and series A rounds comprise 64% of funding activity this quarter. Meanwhile, series B and C rounds are continuing to increase their share of the total 2015 deals, demonstrating the maturation of the market.
~ Investments relevant to the 50+ market have contributed to nearly half the funding in the last five years, with the number of deals as a percent of all digital health steadily increasing.
2014 Year End StartUp Health Insights ReportStartUp Health
2014 was a record year for digital health with $6.5B invested, a 125% increase from the total amount invested in 2013. Our report provides a snapshot of the market’s top deals, subsectors, investors and more.
Download full report at http://startuphealth.com/insights/2014
2016 is on track to be the biggest year yet for digital health funding. Q3 was significant with almost $2.4B in deals, nearly half of which were international. We continue to see the market expand globally, with several large deals taking place both in the US and overseas.
StartUp Health Insights Funding Report Q1 2017StartUp Health
If the first quarter of 2017 is any indication of what’s to come, 2017 is going to be another important year for digital health funding. Among this quarter’s most notable developments, the population health sector saw a large number of deals, Los Angeles emerged as a hotspot of digital health funding, and cancer detection ‘startup’ GRAIL had a record-breaking Series B further displaying the inevitable trend of ‘digital’ weaving into the fabric of every other health/healthcare sector.
Start up health Insights Digital Health Funding Rankings 2016 Mid Year RankingDexter Wee
Source : Startuphealth.com
Digital Health Funding Ranking 2016 Mid Year Report
Seed and Series A deals are 65 % of the funding rounds.
7600 startups around the world.
StartUp Health - Private Market Perspectives - Digital Healthcare Innovation ...Healthegy
Presentation by StartUp Health at Digital Healthcare Innovation Summit 2016.
Participant:
Katya Hancock, Director of Strategic Partnerships – StartUp Health
Introduced By:
Tom Salemi, Content Director – Healthegy
Powered by:
Healthegy
For more healthcare innovation
Visit us at Healthegy.com
StartUp Health - The Transformation MindsetStartUp Health
We are in a unique moment. The conditions are set for the reimagination of healthcare. The creative destruction of the industry lifecycle by a new generation of entrepreneurs has led to two different organizational mindsets.
StartUp Health Insights Report - Digital Health Funding Data 2015 Q1StartUp Health
What happened in the beginning of 2015?
~Investors backed later stage digital health companies as the market matures
~Funding in breakout metro areas including San Diego and Denver grew significantly, but the Bay Area continues to lead with $390M
~Wellness startups increased in popularity to become the second most active subsector
~Close to 41% of all digital health funding YTD has 50+ relevance
StartUp Health Insights Digital Health Funding Rankings Q3 2015 ReportStartUp Health
Q3 2015 continues to demonstrate a trend towards digital health market maturity with an increase of investment dollars combined with larger, less frequent deals.
~ Benefits and insurance solutions remain at the top of the deals list for 2015, particularly as these businesses become more capital intensive. Genomics companies are also beginning to attract funding as the line between biotech and consumer health blurs.
~ While it’s no surprise that the Bay Area continues to bring in the most funding YTD, newer markets are also growing. With Chicago, Salt Lake City and South Florida each taking in over $125M, it’s clear that investment opportunities are everywhere.
~ Keeping with last year’s trend, seed and series A rounds comprise 64% of funding activity this quarter. Meanwhile, series B and C rounds are continuing to increase their share of the total 2015 deals, demonstrating the maturation of the market.
~ Investments relevant to the 50+ market have contributed to nearly half the funding in the last five years, with the number of deals as a percent of all digital health steadily increasing.
2014 Year End StartUp Health Insights ReportStartUp Health
2014 was a record year for digital health with $6.5B invested, a 125% increase from the total amount invested in 2013. Our report provides a snapshot of the market’s top deals, subsectors, investors and more.
Download full report at http://startuphealth.com/insights/2014
2016 is on track to be the biggest year yet for digital health funding. Q3 was significant with almost $2.4B in deals, nearly half of which were international. We continue to see the market expand globally, with several large deals taking place both in the US and overseas.
StartUp Health Insights Funding Report Q1 2017StartUp Health
If the first quarter of 2017 is any indication of what’s to come, 2017 is going to be another important year for digital health funding. Among this quarter’s most notable developments, the population health sector saw a large number of deals, Los Angeles emerged as a hotspot of digital health funding, and cancer detection ‘startup’ GRAIL had a record-breaking Series B further displaying the inevitable trend of ‘digital’ weaving into the fabric of every other health/healthcare sector.
Start up health Insights Digital Health Funding Rankings 2016 Mid Year RankingDexter Wee
Source : Startuphealth.com
Digital Health Funding Ranking 2016 Mid Year Report
Seed and Series A deals are 65 % of the funding rounds.
7600 startups around the world.
StartUp Health - Private Market Perspectives - Digital Healthcare Innovation ...Healthegy
Presentation by StartUp Health at Digital Healthcare Innovation Summit 2016.
Participant:
Katya Hancock, Director of Strategic Partnerships – StartUp Health
Introduced By:
Tom Salemi, Content Director – Healthegy
Powered by:
Healthegy
For more healthcare innovation
Visit us at Healthegy.com
StartUp Health - The Transformation MindsetStartUp Health
We are in a unique moment. The conditions are set for the reimagination of healthcare. The creative destruction of the industry lifecycle by a new generation of entrepreneurs has led to two different organizational mindsets.
StartUp Health Insights Funding Report Q3 2017 YTDStartUp Health
Digital health funding broke all previous records in Q3, with 2017 YTD funding surpassing $9.0B. Assuming
momentum continues through Q4, we’ll finish 2017 well past $10B, a significant signal of support for
entrepreneurs working to achieve their Health Moonshots. Despite the headlines and uncertainty surrounding
healthcare reform, investment into digital health companies continues to accelerate.
StartUp Health Insights - Digital Health Funding Rankings Q3 2014StartUp Health
If you thought last year was big for digital health funding, take a look at this year's numbers. According to StartUp Health's Q3 funding report, investors have already poured $5 billion into digital health companies. That means funding in the sector isn't just higher than last year's total, it's on track to double it. Our new report includes the top 10 largest deals, as well as the top 10 (or so) most active investors, subsectors and metro areas. And it’s free - so dive in!
StartUp Health Insights 2016 Midyear ReportStartUp Health
The digital health market broke historic records for midyear funding as investment reached $3.9B. Seed and Series A financing rounds are substantially equal in number, demonstrating a still thriving early-stage innovation landscape. Most funding dollars are being funneled to Series A rounds, creating opportunities for companies with validated solutions.
2017 StartUp Health Insights Year End ReportStartUp Health
As predicted, digital health investment reached new heights in 2017 with $11.5B in funding across 794 deals. Looking beyond the
numbers provides insight into a sector transitioning to a more mature phase. Deal activity at the early stage has fueled a startup
wave and a maturing market with more later-stage opportunities is attracting new investment globally. 2018 is poised to be a
dynamic year in terms of digital health funding activity, M&A and breakout successes, and experimentation paving the way for
new advancements.
Digital Health Funding For The 50+ market - 2014 Q3 YTDSanjay Khurana
While investment in the 50+ market accounts for 44% ($2.2B) of the overall YTD investment in Digital Health
($5.0B), it is estimated that 50+ focused companies comprise only 12% ($269M) of that subset. For consumers
who spend $1.6 trillion on healthcare, this represents an unmet need for innovation and opportunity for growth.
StartUp Health Insights Global Digital Health Funding Report Q1 2018StartUp Health
2018 Q1 continued the wave of digital health investment activity - the most deal volume of any first quarter since we’ve been tracking data - totaling $2.8B of investment across 191 deals. In addition, we’re seeing more deal flow at every stage, across a spectrum of companies and technologies, from an increasing ecosystem of investors.
StartUp Health Insights Global Digital Health Funding Report: 2018 Year End R...StartUp Health
Welcome to the most-funded year ever in digital health. Investments topped hundreds of millions of US dollars for the first time, with funds funneling to a broader range of cities like Bengaluru and Nashville. Globally, investors are on track to nearly double their 2017 investments, demonstrating long-term commitments, as well as overall growth potential in the market. The digital health market is as potent as ever.
The Commonwealth Fund - Putting the Patient at the Center of the Digital Univ...Healthegy
Keynote Address - Presentation by Commonwealth Fund at Digital Healthcare Innovation Summit 2016
Participant:
David Blumenthal, MD, MPP, President & CEO – Commonwealth Fund
Introduced By:
Robert Mittendorff, MD, MBA, Partner – Norwest Venture Partners
Powered by:
Healthegy
For more healthcare innovation
Visit us at Healthegy.com
Silicon Valley Bank’s annual healthcare M&A report, Trends in Healthcare Investments and Exits, examines the merger and acquisition and IPO activity of private, venture-backed bio-pharma and medical device companies.
The study found that healthcare IPOs tripled in 2013, leading to record potential IPO/big exit returns of $12.5 billion.
For a detailed analysis access the report at: http://www.svb.com/healthcare-report_2014/.
**Report updated on 8/4/2014
StartUp Health Insights Global Digital Health Funding Report Q3 2018StartUp Health
A new benchmark has been set in the digital health market in Q3 2018, surpassing 2017 Q3 funding by almost $2B, hitting an all
time high Q3 mark of $11.1B. Record numbers of mid- and late-stage deals serve as a stabilizing force, creating market maturity
parallel to fund growth. International investments surge with Beijing as the home of five of the top ten international deals, and
European cities serving up an abundance of early-stage deals. With investors outpacing their 2017 totals, the digital health
market continues to be one of the fastest growing segments of the healthcare industry.
4Q 2013: Digital Health Insights Report for the 50+ Market: Sanjay Khurana
StartUp Health and AARP announce the first ever digital health funding insights report evaluating the 50+ market. This report highlights the encouraging rise in health innovation among a growing population with increased medical needs.
2018 StartUp Health Insights Global Digital Health Funding Report 2018 MidyearStartUp Health
The first half of 2018 has brought an increase in deal volume and a total of $6.1B invested in digital health companies across the globe - showing a heightened confidence in the sector.
In our annual report on the healthcare industry, Silicon Valley Bank analyzes the fundraising, investment, M&A and IPO activity of private, venture-backed biopharma, medical device and diagnostic/tools companies.
Silicon Valley Bank’s Trends in Healthcare Investments and Exits report analyzes the fundraising, investment, M&A and IPO activity of private, venture-backed biopharma, medical device and diagnostic/tools companies. Report author Jon Norris also gives his annual forecast of what’s likely to happen in 2016.
The Halo Report is a nationwide survey of Angel Groups' investment activity produced by the Angel Resource Institute, Silicon Valley Bank and CB Insights. The Q1 2014 Halo Report finds median round sizes increased to $980K per deal, and pre-money valuations rose to $2.7 million in the quarter. Investments in Internet-related companies jumped significantly, while dollars invested in mobile and healthcare companies dropped.
Silicon Valley Bank's Life Science and Healthcare Startup Outlook Report examines how the industry's executives view 2017's opportunities and challenges. The report includes startups' thoughts on public policy issues as well as their expectations for fundraising and hiring.
Silicon Valley Bank’s annual Startup Outlook survey provides insight into how startups in the US, UK and China are feeling about the year ahead. The 2016 report finds that while startups across the globe are eternally optimistic, they are preparing for a new reality.
Learn more about the Startup Outlook Report and view the UK and China reports at www.svb.com/IEO.
StartUp Health’s Annual Insights Report: The Year Digital Health Hit its Stri...Jill Gilbert
2017 is on track to be the biggest year yet for digital health funding, with almost $2.4B in deals in Q3 alone, according to StartUp Health Insights’ 2016 Q3 Report. With a record quarter on the books and no signs of funding slowing down, join the Director of StartUp Health Academy as she shares the latest market trends and advances in digital health technology and what’s in store over the next quarter, next year, and 10+ years from now.
Top 12 Venture Capital Firms Funding the 50+ MarketSanjay Khurana
Report takes a closer look at the top venture capitalists in 50+ investing in Digital Health and the areas and the areas with health they like to invest in.
StartUp Health Insights Funding Report Q3 2017 YTDStartUp Health
Digital health funding broke all previous records in Q3, with 2017 YTD funding surpassing $9.0B. Assuming
momentum continues through Q4, we’ll finish 2017 well past $10B, a significant signal of support for
entrepreneurs working to achieve their Health Moonshots. Despite the headlines and uncertainty surrounding
healthcare reform, investment into digital health companies continues to accelerate.
StartUp Health Insights - Digital Health Funding Rankings Q3 2014StartUp Health
If you thought last year was big for digital health funding, take a look at this year's numbers. According to StartUp Health's Q3 funding report, investors have already poured $5 billion into digital health companies. That means funding in the sector isn't just higher than last year's total, it's on track to double it. Our new report includes the top 10 largest deals, as well as the top 10 (or so) most active investors, subsectors and metro areas. And it’s free - so dive in!
StartUp Health Insights 2016 Midyear ReportStartUp Health
The digital health market broke historic records for midyear funding as investment reached $3.9B. Seed and Series A financing rounds are substantially equal in number, demonstrating a still thriving early-stage innovation landscape. Most funding dollars are being funneled to Series A rounds, creating opportunities for companies with validated solutions.
2017 StartUp Health Insights Year End ReportStartUp Health
As predicted, digital health investment reached new heights in 2017 with $11.5B in funding across 794 deals. Looking beyond the
numbers provides insight into a sector transitioning to a more mature phase. Deal activity at the early stage has fueled a startup
wave and a maturing market with more later-stage opportunities is attracting new investment globally. 2018 is poised to be a
dynamic year in terms of digital health funding activity, M&A and breakout successes, and experimentation paving the way for
new advancements.
Digital Health Funding For The 50+ market - 2014 Q3 YTDSanjay Khurana
While investment in the 50+ market accounts for 44% ($2.2B) of the overall YTD investment in Digital Health
($5.0B), it is estimated that 50+ focused companies comprise only 12% ($269M) of that subset. For consumers
who spend $1.6 trillion on healthcare, this represents an unmet need for innovation and opportunity for growth.
StartUp Health Insights Global Digital Health Funding Report Q1 2018StartUp Health
2018 Q1 continued the wave of digital health investment activity - the most deal volume of any first quarter since we’ve been tracking data - totaling $2.8B of investment across 191 deals. In addition, we’re seeing more deal flow at every stage, across a spectrum of companies and technologies, from an increasing ecosystem of investors.
StartUp Health Insights Global Digital Health Funding Report: 2018 Year End R...StartUp Health
Welcome to the most-funded year ever in digital health. Investments topped hundreds of millions of US dollars for the first time, with funds funneling to a broader range of cities like Bengaluru and Nashville. Globally, investors are on track to nearly double their 2017 investments, demonstrating long-term commitments, as well as overall growth potential in the market. The digital health market is as potent as ever.
The Commonwealth Fund - Putting the Patient at the Center of the Digital Univ...Healthegy
Keynote Address - Presentation by Commonwealth Fund at Digital Healthcare Innovation Summit 2016
Participant:
David Blumenthal, MD, MPP, President & CEO – Commonwealth Fund
Introduced By:
Robert Mittendorff, MD, MBA, Partner – Norwest Venture Partners
Powered by:
Healthegy
For more healthcare innovation
Visit us at Healthegy.com
Silicon Valley Bank’s annual healthcare M&A report, Trends in Healthcare Investments and Exits, examines the merger and acquisition and IPO activity of private, venture-backed bio-pharma and medical device companies.
The study found that healthcare IPOs tripled in 2013, leading to record potential IPO/big exit returns of $12.5 billion.
For a detailed analysis access the report at: http://www.svb.com/healthcare-report_2014/.
**Report updated on 8/4/2014
StartUp Health Insights Global Digital Health Funding Report Q3 2018StartUp Health
A new benchmark has been set in the digital health market in Q3 2018, surpassing 2017 Q3 funding by almost $2B, hitting an all
time high Q3 mark of $11.1B. Record numbers of mid- and late-stage deals serve as a stabilizing force, creating market maturity
parallel to fund growth. International investments surge with Beijing as the home of five of the top ten international deals, and
European cities serving up an abundance of early-stage deals. With investors outpacing their 2017 totals, the digital health
market continues to be one of the fastest growing segments of the healthcare industry.
4Q 2013: Digital Health Insights Report for the 50+ Market: Sanjay Khurana
StartUp Health and AARP announce the first ever digital health funding insights report evaluating the 50+ market. This report highlights the encouraging rise in health innovation among a growing population with increased medical needs.
2018 StartUp Health Insights Global Digital Health Funding Report 2018 MidyearStartUp Health
The first half of 2018 has brought an increase in deal volume and a total of $6.1B invested in digital health companies across the globe - showing a heightened confidence in the sector.
In our annual report on the healthcare industry, Silicon Valley Bank analyzes the fundraising, investment, M&A and IPO activity of private, venture-backed biopharma, medical device and diagnostic/tools companies.
Silicon Valley Bank’s Trends in Healthcare Investments and Exits report analyzes the fundraising, investment, M&A and IPO activity of private, venture-backed biopharma, medical device and diagnostic/tools companies. Report author Jon Norris also gives his annual forecast of what’s likely to happen in 2016.
The Halo Report is a nationwide survey of Angel Groups' investment activity produced by the Angel Resource Institute, Silicon Valley Bank and CB Insights. The Q1 2014 Halo Report finds median round sizes increased to $980K per deal, and pre-money valuations rose to $2.7 million in the quarter. Investments in Internet-related companies jumped significantly, while dollars invested in mobile and healthcare companies dropped.
Silicon Valley Bank's Life Science and Healthcare Startup Outlook Report examines how the industry's executives view 2017's opportunities and challenges. The report includes startups' thoughts on public policy issues as well as their expectations for fundraising and hiring.
Silicon Valley Bank’s annual Startup Outlook survey provides insight into how startups in the US, UK and China are feeling about the year ahead. The 2016 report finds that while startups across the globe are eternally optimistic, they are preparing for a new reality.
Learn more about the Startup Outlook Report and view the UK and China reports at www.svb.com/IEO.
StartUp Health’s Annual Insights Report: The Year Digital Health Hit its Stri...Jill Gilbert
2017 is on track to be the biggest year yet for digital health funding, with almost $2.4B in deals in Q3 alone, according to StartUp Health Insights’ 2016 Q3 Report. With a record quarter on the books and no signs of funding slowing down, join the Director of StartUp Health Academy as she shares the latest market trends and advances in digital health technology and what’s in store over the next quarter, next year, and 10+ years from now.
Top 12 Venture Capital Firms Funding the 50+ MarketSanjay Khurana
Report takes a closer look at the top venture capitalists in 50+ investing in Digital Health and the areas and the areas with health they like to invest in.
2013 Midyear Digital Health Funding by @Rock_HealthRock Health
A review of venture capital funding of digital health companies in 2013, totaling $849M through June (Q2). This report covers the major companies, investors and trends in digital health that are emerging in 2013. Purchase this report here: https://gumroad.com/l/TgefY
Digital Health Funding 2013 Year in Review by @Rock_HealthRock Health
A summary of the companies, investors and themes that drove digital health funding to a record $1.97B in 2013. Includes details on crowdfunding, exits, and digital health in the public markets. Purchase this report here: https://gumroad.com/l/tZYVH
2014 MN Investment Report - Life SciencesGreg Groppoli
This is a report of life science related investments raised by Minnesota companies in all of 2014. Also data on the previous six years of investment activity in Minnesota. Any questions, contact me at ggroppoli@lifesciencealley.org
Digital Health Funding 2014 Midyear Report by @Rock_HealthRock Health
A summary of the companies, investors and themes that drove digital health funding to a record $2.3B only halfway through 2014, exceeding the entire 2013 total. Includes details on crowdfunding, exits, and digital health in the public markets, encompassing our new index of publicly-traded digital health companies. Purchase this report here: https://gumroad.com/l/WURST
Updated on July 21, 2014 to reflect final Q2 data on venture funding and deals.
3Q 2013: Digital Health Insights Report for the 50+ Market: Sanjay Khurana
StartUp Health and AARP announce the first ever digital health funding insights report evaluating the 50+ market. This report highlights the encouraging rise in health innovation among a growing population with increased medical needs. Download at www.startuphealth.com/aarp
HealthXL Digital Health Success Stories Report Part OneMaeve Lyons
Part 1 of HealthXL’s ‘Digital Health Success Stories’ report is now available and delves into some of the recent successes in medical tech and asks the experts what it all means.
Key Points:
Multi-million dollar investments don’t always mean success. Success looks different to each stakeholder involved in digital health.
The winners in digital health will be those who provide real solutions to problems at a reduced cost.
Part 1 of HealthXL’s ‘Digital Health Success Stories’ report comprises an in-depth view of the progress of digital health, case studies, along with opinion from some key players in the industry.
Digital health empowers us with ways to improve outcomes and increase efficiency.
Part 2 of our report will look at how we can learn from failures in digital health, available [when available and how to access].
Problem 1Pro Forma Income Statement and Balance SheetBelow is the .docxChantellPantoja184
Problem 1Pro Forma Income Statement and Balance SheetBelow is the income statement and balance sheet for Blue Bill Corporation for 2013. Based on the historical statements and theadditional information provided, construct the firm's pro forma income statement and balance sheet for 2014.Blue Bill CorporationIncome StatementFor the year ended 2013Projected201220132014Revenue$60,000$63,000Cost of goods sold42,00044,100Gross margin18,00018,900SG&A expense6,0006,300Depreciation expense1,8002,000Earnings Before Interest and Taxes (EBIT)10,20010,600Interest expense1,5001,800Taxable income8,7008,800Income Tax Expense3,0453,080Net income5,6555,720Dividends750800To retained earnings$4,905$4,920Additional income statement information:Sales will increase by 5% in 2014 from 2013 levels.COGS and SG&A will be the average percent of sales for the last 2 years.Depreciation expense will increase to $2,200.Interest expense will be $1,900.The tax rate is 35%.Dividend payout will increase to $850.Blue Bill CorporationBalance SheetDecember 31, 2013Projected20132014Current assetsCash$8,000Accounts receivable3,150Inventory9,450Total current assets20,600Property, plant, and equipment (PP&E)28,500Accumulated depreciation16,400Net PP&E12,100Total assets$32,700Current liabilitesAccounts payable$3,780Bank loan (10%)3,200Other current liabilities1,250Total current liabilities8,230Long-term debt (12%)4,800Common stock1,250Retained earnings18,420Total liabilities and equity$32,700Additional balance sheet information:The minimum cash balance is 12% of sales.Working capital accounts (accounts receivable, accounts payable, and inventory) will be the same percent of sales in 2014 as they were in 2013.$8,350 of new PP&E will be purchased in 2014.Other current liabilities will be 3% of sales in 2014.There will be no changes in the common stock or long-term debt accounts.The plug figure (the last number entered that makes the balance sheet balance) is bank loan.
1
Rough Draft
Rough Draft
Rasmussen College
Metro Dental Care is a dental office that provides affordable, convenient, and high quality of care to patients. As a patient at Metro, I personally believe that Metro Dental Care is one of the best dental clinics around, and that’s why I have chosen this company. Metro Dental Care measures their results by recording patient satisfaction.
Managing financial reports, and the quality of service they provide to their customers. Furthermore, the dentists and staff at Metro Dental Care know how important your smile is. Their mission statement states “We pride ourselves in making your smile look great so you not only look good, but feel confident with your smile.”
Metro Dental Care offers convenience for their patients with more than 40 offices throughout the Minneapolis and St. Paul metro area offering flexible hours including early morning, evening and Saturday appointments. Whether you work or live Metro Dental Care has a location near you. Metro Dental .
Cover SheetProject Analysis ByMatthew PankeyBBA in Finance2011-20MerrileeDelvalle969
Cover SheetProject Analysis By:Matthew PankeyBBA in Finance2011-2021MGT 4810 W1-W2 Fall 2022
Executive SummaryExecutive Summary Johnson & Johnson is a multinational American company with headquarters in New Bunswick, New Jersey. Medical devices, pharmaceuticals, and consumer health are the three main business sectors of Johnson & Johnson, which was founded in 1886. J&J is a Fortune 500 firm with about 250 subsidiary businesses that operate in more than 60 countries and sell goods in more than 175 nations. To stand out from rivals, Johnson & Johnson relies on its products and innovation. With the help of this company analysis, students can examine every facet of Johnson & Johnson's operations as consultants. This pertinent data may be used to shed light on how J&J might enhance internal and external operations while enhancing its financial performance and stockholder value. The Strategic Management textbook and other trustworthy sources, such as Johnson & Johnson's annual reports, investor website, and news releases, were used to compile all of the information for this research. Through this capstone project, students can examine pertinent corporate finances and gain knowledge about the potential pitfalls of their chosen career pathways.I was able to get substantial Microsoft Excel knowledge with this assignment, which will help me as I begin to improve my career-related skills. Due to the significant study and analysis required to create each tool, I also had to learn good time management techniques. When examining a company's financials and annual reports to estimate its value, I also feel as though I learned knowledge.
Table of ContentsTable of ContentsTool 1:Historical AnalysisPage 4Tool 2:Mission Statement AnalysisPage 5Tool 3:Remote Environment AnalysisPage 7Tool 4:Competitive Profile MatrixPage 12Tool 5:Internal Factor EvaluationPage 14Tool 6:CohesionPage 17Tool 7:Generic StrategyPage 20Tool 8:Perceptual MappingPage 22Tool 9:GlobalizationPage 23Tool 10:Financial Ratios and BenchmarkingPage 25Tool 11:SWOTPage 30Tool 12:Financing Recommendations for SWOTPage 35
Tool 1Historical AnalysisPurpose: Identify which strategies have historically been successful and how they have affected revenue by relating recent strategic events inside the company to consumer health, medicines, medical devices, and overall revenues. Findings from this research will be used in a SWOT analysis to identify strengths and weaknesses. Data was taken from yearly reports by Johnson & Johnson.YearsGross RevenueConsumer HealthPharmaceuticalMedical Devices2011$82,584$14,053$45,572$22,9592012$82,059$13,898$42,198$25,9632013$81,581$13,853$40,734$26,9942014$76,450$13,602$36,256$26,5922015$71,890$13,307$33,464$25,1192016$70,074$13,507$31,430$25,1372017$74,331$14,496$32,313$27,5222018$71,312$14,697$28,125$28,4902019$67,224$14,447$25,351$27,4262020$65,030$14,883$24,368$25,7792021$93,775$14,635$52,080$27,060Recent Strategic Events2, 3March 2011: Acquires Crucell, a biopharmac ...
cover sheetProject Analysis ByMatthew PankeyBBA in Finance2011-20simisterchristen
cover sheetProject Analysis By:Matthew PankeyBBA in Finance2011-2021MGT 4810 W1-W2 Fall 2022
Executive SummaryExecutive Summary Johnson & Johnson is a multinational American company with headquarters in New Bunswick, New Jersey. Medical devices, pharmaceuticals, and consumer health are the three main business sectors of Johnson & Johnson, which was founded in 1886. J&J is a Fortune 500 firm with about 250 subsidiary businesses that operate in more than 60 countries and sell goods in more than 175 nations. To stand out from rivals, Johnson & Johnson relies on its products and innovation. With the help of this company analysis, students can examine every facet of Johnson & Johnson's operations as consultants. This pertinent data may be used to shed light on how J&J might enhance internal and external operations while enhancing its financial performance and stockholder value. The Strategic Management textbook and other trustworthy sources, such as Johnson & Johnson's annual reports, investor website, and news releases, were used to compile all of the information for this research. Through this capstone project, students can examine pertinent corporate finances and gain knowledge about the potential pitfalls of their chosen career pathways.I was able to get substantial Microsoft Excel knowledge with this assignment, which will help me as I begin to improve my career-related skills. Due to the significant study and analysis required to create each tool, I also had to learn good time management techniques. When examining a company's financials and annual reports to estimate its value, I also feel as though I learned knowledge.
Table of ContentsTable of ContentsTool 1:Historical AnalysisPage 4Tool 2:Mission Statement AnalysisPage 5Tool 3:Remote Environment AnalysisPage 7Tool 4:Competitive Profile MatrixPage 12Tool 5:Internal Factor EvaluationPage 14Tool 6:CohesionPage 17Tool 7:Generic StrategyPage 20Tool 8:Perceptual MappingPage 22Tool 9:GlobalizationPage 23Tool 10:Financial Ratios and BenchmarkingPage 25Tool 11:SWOTPage 30Tool 12:Financing Recommendations for SWOTPage 35
Tool1Historical AnalysisPurpose: Identify which strategies have historically been successful and how they have affected revenue by relating recent strategic events inside the company to consumer health, medicines, medical devices, and overall revenues. Findings from this research will be used in a SWOT analysis to identify strengths and weaknesses. Data was taken from yearly reports by Johnson & Johnson.YearsGross RevenueConsumer HealthPharmaceuticalMedical Devices2011$82,584$14,053$45,572$22,9592012$82,059$13,898$42,198$25,9632013$81,581$13,853$40,734$26,9942014$76,450$13,602$36,256$26,5922015$71,890$13,307$33,464$25,1192016$70,074$13,507$31,430$25,1372017$74,331$14,496$32,313$27,5222018$71,312$14,697$28,125$28,4902019$67,224$14,447$25,351$27,4262020$65,030$14,883$24,368$25,7792021$93,775$14,635$52,080$27,060Recent Strategic Events2, 3March 2011: Acquires Crucell, a biopharmace ...
Startup Health creert een eigen categorie business incubators. In 10 jaar tijd wil zij 1.000 startup wereldwijd verbinden aan de uitdaging om de gezondheidszorg dramatisch te vernieuwen. Een waar 'Global Entrepreneurship' aanpak, die het ambitieniveau van Amerikaanse ondernemers weergeeft.
Digital Health Success Stories Report - Part 1Tom Parsons
Part 1 of HealthXL’s ‘Digital Health Success Stories’ report is now available and delves into some of the recent successes in healthcare technology and asks the experts what it all means.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.